Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-22-002646

Options or other derivatives

  • Chief Legal Officer acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ZDRAVESKI ZORAN Chief Legal Officer 2022-01-18 Grant or award · Stock Option (Right to Buy) +85,000 85,000 D
Loading xslF345X03/doc4.xml…